The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer’s Disease: The Okayama Depression and Apathy Project (ODAP) - Concepedia

Concepedia

Publication | Closed Access

The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer’s Disease: The Okayama Depression and Apathy Project (ODAP)

20

Citations

12

References

2020

Year

Mami Takemoto, Yasuyuki Ohta, Nozomi Hishikawa, Toru Yamashita, Emi Nomura, Keiichiro Tsunoda, Ryo Sasaki, Koh Tadokoro, Namiko Matsumoto, Yoshio Omote,

Journal of Alzheimer s Disease

Abstract

These results provide novel information on the efficacy of sertraline and escitalopram in the treatment of apathy and depression, respectively, in patients with AD.

References

	Year	Citations
“Mini-mental state” Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh Journal of Psychiatric Research	1975	85.9K
Pathologic correlates of incidental MRI white matter signal hyperintensities Franz Fazekas, R. Kleinert, H. Offenbacher, Neurology EngineeringElderly PatientsWhite MatterBrain LesionMagnetic Resonance Imaging	1993	1.6K
Validation of the geriatric depression scale-short form among inpatients Emerson L. Lesher, Jeffrey S. Berryhill Journal of Clinical Psychology Geriatric PsychiatryPsychiatryGeriatricsMood SymptomSubcortical Ischemic Depression	1994	499
Apathy following cerebrovascular lesions. Sergio Starkstein, J. Paul Fedoroff, T R Price, Stroke	1993	420
Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes Daniel Weintraub, Paul B. Rosenberg, Barbara K. Martin, American Journal of Geriatric Psychiatry Alzheimer's DiseasePsychiatryPsychotropic MedicationDementiaSubcortical Ischemic Depression	2010	183
Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition Shana D. Stites, Kristin Harkins, Jonathan D. Rubright, Alzheimer Disease & Associated Disorders	2018	150
Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats Yuji Kitaichi, Takeshi Inoue, Shin Nakagawa, European Journal of Pharmacology PsychiatryNeurophysiologyNeuroanatomyPhysiologyNeurotransmitter	2010	132
Comparison of Sertraline, Venlafaxine and Desipramine Effects on Depression, Cognition and the Daily Living Activities in Alzheimer Patients Naghmeh Mokhber, Ebrahim Abdollahian, Atefeh Soltanifar, Pharmacopsychiatry	2014	61
Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer Disease Carolyn W. Zhu, Hillel Grossman, Mary Sano American Journal of Geriatric Psychiatry Alzheimer's DiseaseAgingCore SymptomNeurologyAlzheimer Disease	2018	47
Escitalopram for agitation in Alzheimer's disease (S‐CitAD): Methods and design of an investigator‐initiated, randomized, controlled, multicenter clinical trial Stephan Ehrhardt, Anton P. Porsteinsson, Cynthia A. Munro, Alzheimer s & Dementia	2019	45

Page 1